Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
NCT07079735· Phase 2/3· Columbia University· Source
Contact: Afsana Rahman, MD
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error